Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2020   76,457        
Beginning balance at Dec. 31, 2020 $ 1,210,149 $ 765 $ 1,394,009 $ (204,112) $ 12,634 $ 6,853
Ending balance (in shares) at Mar. 31, 2021   78,319        
Ending balance at Mar. 31, 2021 1,311,320 $ 783 1,489,168 (181,992) (5,360) 8,721
Beginning balance (in shares) at Dec. 31, 2020   76,457        
Beginning balance at Dec. 31, 2020 1,210,149 $ 765 1,394,009 (204,112) 12,634 6,853
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 67,624     66,998   626
Unrealized gain (loss) on available-for-sale securities (7,368)       (7,323) (45)
Unrealized gain (loss) on interest rate swaps 6,054       6,025 29
Issued shares of common stock (in shares)   1,639        
Issued shares of common stock 102,889 $ 16 102,873      
Equity-based compensation 14,250   4,241     10,009
Issuance (repurchase) of vested equity-based compensation shares (in shares)   323        
Issuance (repurchase) of vested equity-based compensation shares (14,017) $ 3 (14,020)      
Dividends and distributions (57,032)     (56,416)   (616)
Ending balance (in shares) at Jun. 30, 2021   78,419        
Ending balance at Jun. 30, 2021 1,322,549 $ 784 1,487,103 (193,530) 11,336 16,856
Beginning balance (in shares) at Mar. 31, 2021   78,319        
Beginning balance at Mar. 31, 2021 1,311,320 $ 783 1,489,168 (181,992) (5,360) 8,721
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 16,408     15,974   434
Unrealized gain (loss) on available-for-sale securities 11,943       11,905 38
Unrealized gain (loss) on interest rate swaps 4,814       4,791 23
Issued shares of common stock (37)   (37)      
Equity-based compensation 9,572   1,602     7,970
Issuance (repurchase) of vested equity-based compensation shares (in shares)   100        
Issuance (repurchase) of vested equity-based compensation shares (3,629) $ 1 (3,630)      
Dividends and distributions (27,842)     (27,512)   (330)
Ending balance (in shares) at Jun. 30, 2021   78,419        
Ending balance at Jun. 30, 2021 1,322,549 $ 784 1,487,103 (193,530) 11,336 16,856
Beginning balance (in shares) at Dec. 31, 2021   85,327        
Beginning balance at Dec. 31, 2021 1,566,515 $ 853 1,727,667 (193,706) 9,904 21,797
Ending balance (in shares) at Mar. 31, 2022   86,720        
Ending balance at Mar. 31, 2022 1,613,994 $ 867 1,783,938 (181,282) (12,341) 22,812
Beginning balance (in shares) at Dec. 31, 2021   85,327        
Beginning balance at Dec. 31, 2021 1,566,515 $ 853 1,727,667 (193,706) 9,904 21,797
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 27,166     26,896   270
Unrealized gain (loss) on available-for-sale securities (44,158)       (43,720) (438)
Unrealized gain (loss) on interest rate swaps 11,801       11,684 117
Issued shares of common stock (in shares)   1,781        
Issued shares of common stock 77,794 $ 18 77,776      
Equity-based compensation 15,933   1,938     13,995
Conversion of Convertible Notes (in shares)   283        
Conversion of Convertible Notes 7,674 $ 3 7,671      
Issuance (repurchase) of vested equity-based compensation shares (in shares)   99        
Issuance (repurchase) of vested equity-based compensation shares (3,162) $ 1 (3,163)      
Dividends and distributions (68,048)     (65,780)   (2,268)
Ending balance (in shares) at Jun. 30, 2022   87,490        
Ending balance at Jun. 30, 2022 1,591,515 $ 875 1,811,889 (232,590) (22,132) 33,473
Beginning balance (in shares) at Mar. 31, 2022   86,720        
Beginning balance at Mar. 31, 2022 1,613,994 $ 867 1,783,938 (181,282) (12,341) 22,812
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (18,538)     (18,449)   (89)
Unrealized gain (loss) on available-for-sale securities (21,448)       (21,188) (260)
Unrealized gain (loss) on interest rate swaps 11,512       11,397 115
Issued shares of common stock (in shares)   731        
Issued shares of common stock 27,934 $ 8 27,926      
Equity-based compensation 12,392   976     11,416
Issuance (repurchase) of vested equity-based compensation shares (in shares)   39        
Issuance (repurchase) of vested equity-based compensation shares (951)   (951)      
Dividends and distributions (33,380)     (32,859)   (521)
Ending balance (in shares) at Jun. 30, 2022   87,490        
Ending balance at Jun. 30, 2022 $ 1,591,515 $ 875 $ 1,811,889 $ (232,590) $ (22,132) $ 33,473